- Home
- NRXS vs COHN Comparison
NRXS vs COHN Comparison
Compare NRXS & COHN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRXS
- COHN
- Stock Information
- Founded
- NRXS 2011
- COHN 1999
- Country
- NRXS United States
- COHN United States
- Employees
- NRXS N/A
- COHN N/A
- Industry
- NRXS
- COHN Investment Bankers/Brokers/Service
- Sector
- NRXS
- COHN Finance
- Exchange
- NRXS Nasdaq
- COHN Nasdaq
- Market Cap
- NRXS 17.8M
- COHN 18.5M
- IPO Year
- NRXS 2023
- COHN N/A
- Fundamental
- Price
- NRXS $2.31
- COHN $9.50
- Analyst Decision
- NRXS
- COHN
- Analyst Count
- NRXS 0
- COHN 0
- Target Price
- NRXS N/A
- COHN N/A
- AVG Volume (30 Days)
- NRXS 22.4K
- COHN 4.6K
- Earning Date
- NRXS 04-08-2025
- COHN 03-05-2025
- Dividend Yield
- NRXS N/A
- COHN 10.53%
- EPS Growth
- NRXS N/A
- COHN N/A
- EPS
- NRXS N/A
- COHN 2.35
- Revenue
- NRXS $2,456,219.00
- COHN $89,555,000.00
- Revenue This Year
- NRXS $383.16
- COHN N/A
- Revenue Next Year
- NRXS N/A
- COHN N/A
- P/E Ratio
- NRXS N/A
- COHN $4.05
- Revenue Growth
- NRXS N/A
- COHN 63.18
- 52 Week Low
- NRXS $2.05
- COHN $6.10
- 52 Week High
- NRXS $3.78
- COHN $12.82
- Technical
- Relative Strength Index (RSI)
- NRXS 38.24
- COHN 43.32
- Support Level
- NRXS $2.39
- COHN $9.43
- Resistance Level
- NRXS $2.51
- COHN $9.79
- Average True Range (ATR)
- NRXS 0.15
- COHN 0.30
- MACD
- NRXS -0.03
- COHN 0.02
- Stochastic Oscillator
- NRXS 7.14
- COHN 37.50
About NRXS Neuraxis Inc.
Neuraxis Inc is a growth stage company is engaged in developing neuromodulation therapies to address chronic and debilitating conditions in children. The company is dedicated to advancing the science with its' proprietary Percutaneous Electrical Nerve Field Stimulation (PENFS) technology. The company focuses on targeted therapies for the pediatric and adolescent population suffering from disorders of gut-brain interaction (DGBIs).
About COHN Cohen & Company Inc.
Cohen & Co Inc is a United States company that delivers financial services in fixed-income markets. It is focused on small-cap banking institutions and has grown to provide an expanding range of capital markets and asset management services. It has three business segments. The Capital Markets segment, which is the key revenue driver, consists of fixed-income sales, trading, matched book repo financing, new issue placements in corporate and securitized products, and advisory services. The Asset Management segment manages assets within collateralized debt obligations, managed accounts, joint ventures, and investment funds. The Principal Investing segment is comprised of investments to earn return rather than to support trading, matched book repo, or other Capital Markets segment activities.